Advanced Filters
noise

atrial-fibrillation Clinical Trials

A listing of atrial-fibrillation medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 473 clinical trials
M Moore B Shoemaker, MD, MSCI

The Vanderbilt Atrial Fibrillation Ablation Registry

The Vanderbilt Atrial Fibrillation Ablation registry (VAFAR) is a prospective clinical and genetic biorepository that systematically enrolls patients undergoing atrial fibrillation (AF) ablation. The registry was started in 2011 and has greater than 1000 AF ablation records with stored blood and DNA samples. The goals of VAFAR are to: 1) …

18 years of age All Phase N/A

Post-Operative Myocardial Incident & Atrial Fibrillation

To explore predictors of major cardio-vascular events after cardiac surgery and trans-catheter valve implantation with a specific interest in studying mechanisms linking pre-operative leukocyte, fat and myocardial phenotypes with post-intervention outcomes.

18 years of age All Phase N/A

Atrial Fibrillation in Active Cancer Patients

Atrial fibrillation is a common complication of both cancer and anticancer drugs but the consequences of such events remain poorly known and are not adressed in both phase III oncological trials and cardiological guidelines. The objective of this study is to create a prospective multicenter international registry of adult patients …

18 years of age All Phase N/A
M Michael Kühne, Prof.

Swiss Atrial Fibrillation Pulmonary Vein Isolation Registry

Registry of patients with atrial fibrillation undergoing catheter-based ablation of atrial fibrillation (pulmonary vein isolation) to determine long-term success rates of catheter-based ablation of atrial fibrillation (pulmonary vein isolation) and to evaluate factors associated with long-term success of catheter-based ablation of atrial fibrillation (pulmonary vein isolation).

18 years of age All Phase N/A
F Frédéric PHILIPPEAU, PH

Biological Bank for Atrial Fibrillation and Stroke

Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical practice. This arrhythmia is responsible for 15% of strokes and more than 30% of strokes on people over 65 years. According to studies, 30 to 40% of isolated atrial fibrillations could be familial. Atrial fibrillation has significant genetic …

18 years of age All Phase N/A
D Daniel Engler, MSc.

Cohort Study for Atrial Fibrillation Risk Stratification

AFHRI is planned as a prospective, single-center cohort study in patients at high risk of AF.

18 - 85 years of age All Phase N/A
C Christine Rutan

Get With the Guidelines Atrial Fibrillation Registry

Get With The Guidelines-Atrial Fibrillation is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for continued research and further …

18 - 125 years of age All Phase N/A
P Peijian Shi, MSc

Large Language Model and Atrial Fibrillation Recurrence

This study aims to develop a risk prediction model for atrial fibrillation (AF) recurrence by leveraging large language model (LLM) technology to analyze semantic relationships across multimodal textual data, including pre-ablation clinical baseline characteristics, echocardiography reports, ambulatory electrocardiogram reports, and procedural records. The proposed model seeks to provide actionable clinical …

18 - 90 years of age All Phase N/A
J Jan Niederdöckl, Dr.

Atrial Fibrillation at the Viennese University Emergency Department

The results of this study could imply that a atrial fibrillation registry, as a tool for structured diagnosis and therapy in patients with atrial fibrillation, may improve patient care for this rapidly growing population.

18 years of age All Phase N/A
K Krysten Gregus

DETECTion of PeriOperative Atrial Fibrillation After Noncardiac Surgery

This is a multicentre prospective cohort study where patients will receive up to 14 days of continuous ECG monitoring by wearing a portable monitoring device, starting within 72 hours after noncardiac surgery.

18 - 120 years of age All Phase N/A

Simplify language using AI